- Exhibit & Support
- Hotel & Travel
To better understand type 2 diabetes management, you have to understand cardiovascular outcome trials (CVOTs). This interactive session will explore the unique properties, A1C-lowering effects, and CVOTs of dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, and sodium–glucose cotransporter 2 inhibitors. Using the data, participants will be able to better advise their patients on diabetes management and evaluate future CVOTs.
At the completion of this application-based activity, participants will be able to: